Monte Rosa Therapeutics (GLUE) Net Equity Issued and Repurchased (2020 - 2026)
Monte Rosa Therapeutics (GLUE) recorded Net Equity Issued and Repurchased of $2.6 million in Q2 2026, down 42.5% from the prior quarter.
Monte Rosa Therapeutics (GLUE) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
On a TTM basis, Monte Rosa Therapeutics' Net Equity Issued and Repurchased came in at $12.83 million as of Jun 30, 2026; for FY2025, it came in at $5.72 million, down 88.6% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -37.6% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $50 million in FY2024 (+100.0%), $25 million in FY2023 (+24.7%), $20.06 million in FY2022 (-91.6%) and $237.75 million in FY2021 (+293.0%).
- Quarterly Net Equity Issued and Repurchased has ranged from $14,000 in Q1 2025 to $49.75 million in Q2 2024 over the past five years.
- Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 834.4% in Q2 2023, against a decline of 99.9% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.52 million (Q1 2026), $5.36 million (Q4 2025) and $348,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Monte Rosa Therapeutics | 1.02 Bn | 428.56 Mn | - | 2.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.60 Mn |
| Mar 31, 2026 | 4.52 Mn |
| Dec 31, 2025 | 5.36 Mn |
| Sep 30, 2025 | 348,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Jun 30, 2024 | 49.75 Mn |
| Mar 31, 2024 | 246,000.00 |
| Dec 31, 2023 | 22.98 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 897,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 6.55 Mn |
| Sep 30, 2022 | 13.26 Mn |
| Jun 30, 2022 | 96,000.00 |
| Mar 31, 2022 | 153,000.00 |
| Sep 30, 2021 | 31.01 Mn |
| Jun 30, 2021 | 63.74 Mn |
| Mar 31, 2021 | 143.00 Mn |
| Sep 30, 2020 | 48.00 Mn |
Monte Rosa Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GLUE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();